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Background: There is a lack of validated instruments to measure the level of burden of Alzheimer’s disease (AD)
on caregivers. The Impact of Alzheimer’s Disease on Caregiver Questionnaire (IADCQ) is a 12-item instrument with a
seven-day recall period that measures AD caregiver’s burden across emotional, physical, social, financial, sleep, and
time aspects. Primary objectives of this study were to evaluate psychometric properties of IADCQ administered on
the Web and to determine most appropriate scoring algorithm.
Methods: A national sample of 200 unpaid AD caregivers participated in this study by completing the Web-based
version of IADCQ and Short Form-12 Health Survey Version 2 (SF-12v2™). The SF-12v2 was used to measure
convergent validity of IADCQ scores and to provide an understanding of the overall health-related quality of life of
sampled AD caregivers.
The IADCQ survey was also completed four weeks later by a randomly selected subgroup of 50 participants to
assess test-retest reliability. Confirmatory factor analysis (CFA) was implemented to test the dimensionality of the
IADCQ items. Classical item-level and scale-level psychometric analyses were conducted to estimate psychometric
characteristics of the instrument. Test-retest reliability was performed to evaluate the instrument’s stability and
consistency over time.
Results: Virtually none (2%) of the respondents had either floor or ceiling effects, indicating the IADCQ covers an
ideal range of burden. A single-factor model obtained appropriate goodness of fit and provided evidence that a
simple sum score of the 12 items of IADCQ can be used to measure AD caregiver’s burden. Scales-level reliability
was supported with a coefficient alpha of 0.93 and an intra-class correlation coefficient (for test-retest reliability) of
0.68 (95% CI: 0.50–0.80). Low-moderate negative correlations were observed between the IADCQ and scales of the
SF-12v2.
Conclusions: The study findings suggest the IADCQ has appropriate psychometric characteristics as a
unidimensional, Web-based measure of AD caregiver burden and is supported by strong model fit statistics from
CFA, high degree of item-level reliability, good internal consistency, moderate test-retest reliability, and moderate
convergent validity. Additional validation of the IADCQ is warranted to ensure invariance between the paper-based
and Web-based administration and to determine an appropriate responder definition.
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Alzheimer’s disease (AD) is an age-related, irreversible,
progressive brain disorder that attacks the brain and
results in increasingly impaired memory, thinking, rea-
soning, and behavior [1,2]. The prevalence of AD is esti-
mated at 5.4 million in the United States (US) and as high
as 24 million globally [3,4]. There were an estimated
454,000 new cases diagnosed in 2010 [5]. Barring signi-
ficant medical breakthroughs, prevalence rates are pre-
dicted to triple by 2050 [6].
The cognitive impairments from AD significantly im-
pact the patient’s activities of daily living [7]. Caregiving
is an inherent part of managing AD, as progressive de-
terioration in intellectual function and other cognitive
skills leads to a decline in the ability to perform activities
of daily living (ADLs) [7]. Caring for patients with AD
poses a large burden on both families and the healthcare
community [5]. Over 35 million people worldwide
currently live with Alzheimer’s disease, and this number
is expected to double by 2030 and more than triple by
2050 to 115 million. In the 2010 World Alzheimer
Report, Alzheimer’s Disease International estimated that
the annual societal costs of dementia worldwide were
US $604 billion, or 1% of the aggregated worldwide gross
domestic product. Alzheimer’s Disease International also
predicted almost a doubling in worldwide societal costs
from US $604 billion in 2010 to US $1,117 billion by 2030
[6]. In the 2010 World Alzheimer Report, a systematic
review of the world literature on the demands of caregiv-
ing looked at 10 studies where time spent assisting with
basic ADLs was quantified covering 25 countries; 13 stud-
ies of time spent in generally supervising the person with
dementia covering 25 countries; and 42 studies of time
spent assisting with basic ADLs and instrumental activities
of daily living (IADLs) combined spanning 30 countries.
The report suggested that caregivers spend an average of
2.0 hours daily supporting basic ADLs, 3.6 hours with
basic ADLs and IADLs combined, and 2.6 hours supervis-
ing the person with dementia. This amounts to an average
weekly total of between 14 hours (ADL alone) and
43 hours (ADL, IADL, and supervision) [6]. In 2011, 15.2
million family and other uncompensated caregivers cared
for patients with AD and other dementias in the US pro-
viding 17.4 billion hours of care valued at more than $210
billion [5]. Family caregivers provide 80% of home care to
AD patients with the level of caregiver burden related to
the extent of the patient’s cognitive impairment and func-
tional abilities [5,6]. Caregivers provided an average of
21.9 hours of care per week [6].
Given the high demands on caregivers of people with
AD, they may experience negative impacts on physical,
psychological, emotional, social, and financial aspects of
their life; some positive effects have also been noted [8-11].
About a third of family caregivers experience symptoms ofdepression, and 61% rate the emotional stress of caregiving
as high or very high [4]. They may rate their own health as
fair or poor and tend to report that serving as a caregiver
worsens their health [4]. Caregivers may also experience
higher levels of depression and stress hormones, reduced
immune function, slow wound healing, and more new
cases of hypertension and coronary heart disease compared
to non-caregivers [12]. Health care costs for caregivers are
estimated to be 8% higher than non-caregivers due to the
physical and emotional toll of caregiving [4]. Caregiver
healthcare is estimated to cost $8.6 billion; this is in
addition to the $210 billion in unpaid caregiver hours [5].
Caregiving also negatively impacts employment status and
work productivity. Of the 44% of caregivers who are
employed part or full time, 65% reported missing work,
going in late, or leaving early, and 20% have taken a leave
of absence [5]. The burden of caregiving and resulting
changes in employment often lead to withdrawal or isola-
tion from the caregiver’s wider social networks, which may
further increase depression and stress [12-14].
Although private or public insurance offers partial
coverage, providing care often results in out-of-pocket
expenditures for the family. In 2008, total per-person
payments from all sources for health care and long-term
care for Medicare beneficiaries with AD and other demen-
tias were 3 times as great as payments for other Medicare
beneficiaries in the same age group [5]. Excluding the con-
tributions of uncompensated caregivers, total pay-
ments for care related to AD and dementia care for
patients 65 years and older were estimated at $200 billion
in 2012 [5].
A caregiver burden instrument specific to AD is neces-
sary to measure the impact of treatment for AD patients
on the lives of their caregivers. The ideal instrument
would be brief, self-administered, and not overly burden-
some to the respondent. A review of the existing care-
giver burden instruments in the published literature
revealed a range of validated and non-validated instru-
ments measuring various aspects of the caregiver experi-
ence, including burden, mood, needs, and quality of life,
across a range of conditions. In a systematic review of
caregiver burden instruments, Deeken et al. [15] identified
28 self-report questionnaires assessing the burden, needs,
and quality of life of informal caregivers. Among the 17
instruments reviewed that specifically focused on care-
giver burden, 10 of the instruments were not specific to
either AD or dementia (eg, Caregiver Strain Index [16],
Burden Assessment Scale [17], Appraisal of Caregiving
Scale [18]); several lacked evidence of rigorous psycho-
metric testing or evidence of adequate validity and reliabil-
ity (eg, Burden Interview [19], Family Burden Scale [20],
Objective Burden Questionnaire [21]; and others were too
lengthy or difficult to administer in a clinical trial setting
(eg, Caregiver Experience Assessment, 105 items [22];
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despite the abundance of caregiver instruments available,
none were appropriate for the purposes of measuring
caregiver burden during the course of a clinical trial evalu-
ating the impact of an experimental treatment on AD
patients. In addition, the Zarit Burden Interview was
assessed but found to be too lengthy to be used in an
Alzheimer’s Disease interventional trial where the care-
giver was asked to complete a number of psychosocial
measures on behalf of the AD patient [10].
Development of Impact of Alzheimer’s Disease on
Caregiver Questionnaire (IADCQ)
In response to the lack of an appropriate AD caregiver
instrument for clinical trials, an effort was undertaken to
develop a new AD caregiver instrument. A review of the
literature on the health-related quality of life (HRQoL)
burden that unpaid caregivers face in caring for an indi-
vidual with AD was first conducted. A Medline search
was conducted using Alzheimer, dementia, caregiver
burden, and caregiver quality of life as search terms from
1980 to 2010. Nineteen articles were found to be relevant.
Eight articles discussed AD caregiver burden in general
and 11 existing instruments were identified. However,
none of these findings fulfilled the criteria of assessing AD
caregiver burden for various reasons such as inability to
implement the instrument in a clinical trial setting, in-
appropriate questions, too lengthy of an instrument, and
not a self-administered instrument.
Based on this review, the initial draft of the Impact of
Alzheimer’s Disease on Caregiver Questionnaire (IADCQ),
consisting of 9 items, was created. To ensure that this
questionnaire adequately captured the key domains that
were most relevant to caregivers of AD patients in asses-
sing the burden of caregiving, 3 focus groups of 21 unpaid
caregivers (21 females and 2 males) of AD patients were
held in Los Angeles, Chicago, and New Orleans. These
focus groups were held to better understand the experi-
ence of caring for a patient with AD and to conduct a cog-
nitive debriefing of the initial draft of the IADCQ. The
focus groups were held to elicit concepts and were con-
ducted with a trained moderator using a semi-structured
interview guide. Caregivers described various impacts on
their HRQoL due to caregiving which included emotional
(worry, frustrated, sad/depressed), social (relationship with
friends and family, relationship with person with AD,
limit activities), physical (aging, diet, weight), sleep (fall-
ing asleep, less sleep, interruption), work (can’t retire,
work at home, cut back on hours worked), time (having
no time to do personal activities, giving up time to care,
making adjustments to schedule), sex life, well-being
(lack of freedom/independence, loss of creativity, needing
to mature faster, loss of self, personality change), and
financial. Caregivers also reported not knowing what toexpect and needing to make decisions for the patient.
They reported that their self-care was impacted and they
felt homebound. Caregivers were asked to evaluate the ini-
tial draft of the IADCQ and provide input on the ques-
tions, response options, and instructions. Saturation was
achieved by the third focus group. Based on the results, a
revised 12-item IADCQ instrument with a 7-day recall
period was developed. This instrument contained the
elements most relevant to caregivers of AD patients in
assessing the burden of care giving: emotional, physical,
social, time, sleep, and financial impact.
The current study details the next steps in IADCQ
development, including a psychometric study of the
IADCQ and ascertaining the most appropriate scoring
algorithm for the instrument.
Methods
Study design
The current study design and psychometric analyses
were selected to establish the internal consistency and
test-retest reliability of the IADCQ. Alzheimer’s disease
caregivers were recruited and entered into a cross-
sectional study to collect data appropriate for most of the
study goals. Finally, to ascertain test-retest reliability, a
subset of those who completed the psychometric study
was randomly invited to participate in a second round of
data collection four weeks later.
Psychometric analyses were specifically selected and
ordered to ensure goals of the study were analyzed
accurately. The IADCQ was first analyzed with confirma-
tory factor analysis (CFA) to assure construct validity; the
data were checked for fit with the original conceptual
framework from previous qualitative development of the
IADCQ. The reliability (eg, internal consistency) was ex-
amined by assessing item-level and scale-level statistics.
Finally, test-retest reliability was examined with intra-class
correlations to determine the strength of the relation-
ship between four-week administrations of the IADCQ.
Pearson correlation coefficients were computed for the
investigation of convergent validity.
Study participants
A national sample of men and women ≥ 18 years of age
who identified themselves as an unpaid caregiver of an
AD patient participated in a cross-sectional, nonrando-
mized, psychometric study. The AD caregivers, who previ-
ously indicated their willingness to be contacted for
research purposes, were recruited via e-mail from a panel
of caregivers in the US managed by a research-panel
vendor. Each caregiver previously self-enrolled to partici-
pate in research related to caregiving for AD patients.
Various approaches were employed to recruit panelists,
such as banners, referrals, natural search optimization,
affiliate marketing, and targeted e-mails. Inclusion and
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in Table 1, were employed to determine the survey candi-
dates’ eligibility. If caregivers were interested and eligible
to participate in the study, they read and provided
informed consent electronically before completing the
demographic questions and the study instrument. Each
initial e-mail was submitted with a unique link. When the
caregiver noted they were willing to participate, the system
created a follow-up email at the correct time with the
same caregiver ID in the secure link. The caregivers were
compensated for participating in the study. This study was
reviewed and approved by the New England Institutional
Review Board.
A total of 200 caregivers completed the online sur-
vey. To assess the test-retest reliability of the IADCQ,
a subgroup of 50 randomly selected caregivers were
asked to repeat the survey four weeks after the initial
survey; 100% of these caregivers completed the second
administration.
Measurements
Description of the IADCQ
The Impact of Alzheimer’s Disease on Caregiver Ques-
tionnaire (IADCQ) is an instrument used to measure the
burden of caregiving and includes items that represent the
key concepts and domains of caregiving for an AD patient.
The current version of the IADCQ has a 7-day recall
period and 12 items. It has a five-point Likert scale with
response choices ranging from “not at all” (0) to “ex-
tremely” (4). The IADCQ measures the burdens associ-
ated with being an AD caregiver across six theorized
domains: emotional, physical, social, financial, sleep, and
impact on time.
The original IADCQ qualitative research [24] helped to
gain a better understanding of the impact of AD patient
caring on caregivers’ HRQoL. The current study is theTable 1 Inclusion and exclusion criteria to recruit for survey p
Inclusion criteria Exc




Informal caregiver to an AD patient Cog
English literacy Able to read and write English sufficiently
to complete the study instrument and
provide the informed consent.first quantitative evaluation of the IADCQ and was de-
signed firstly to evaluate the psychometric characteristics
of a Web-based version of the IADCQ instrument com-
pleted by caregivers of patients with AD and secondly, to
determine the scoring algorithm.
A comprehensive examination of the psychometric
properties of the IADCQ was undertaken in a group of
caregivers for AD patients through a Web-based survey.
The survey was administered twice: (1) at baseline (using
the IADCQ and Short Form-12 Health Survey Version 2
[SF-12v2™]) and (2) four weeks later for a subgroup of
participants (using the IADCQ).
Description of the SF-12v2
In addition to the IADCQ, the SF-12v2 was adminis-
tered in the survey. The SF-12v2 is a generic HRQoL
instrument that contains 12 questions representing 8
domains to provide insight into physical and mental
functioning [25]. It is a valid measure of physical and
mental health often used in large population health sur-
veys or in clinical trials to assess the impact of an inter-
vention on patient HRQoL. It was used to permit a wide
array of HRQoL information, and its psychometric prop-
erties are well defined and known. In addition, it has
accepted responder definitions. In this study, the SF-12v2
was used to measure convergent validity of IADCQ scores
as well as to provide an understanding of the overall
HRQoL of the sampled AD caregivers.
Data analysis
Descriptive statistics were first examined based on
demographics (ie, age, gender, and race) and other char-
acteristics of the AD caregiver participants (ie, caregiver
history, employment status, and missing work time).
Item-level evaluations were assessed to cover aspects




Each participant was required to read the
informed consent form that appeared on their
computer screen prior to beginning the survey.
nitively impaired Possess any of the following conditions:
psychiatric disorder,
developmental disorder that affected cognitive
or emotional functions so that judgment and
reasoning were significantly diminished,
under the influence of/dependent on
drugs/alcohol, or
suffering from degenerative diseases affecting
the brain.
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ordering of item means. The Web-based survey did not
permit missing data; therefore, all 200 subjects had
complete survey data. Survey items were defined to assess
a specified level within a narrow range of the construct for
instrument precision, with some participants scoring the
lowest possible score (ie, floor effects) and others having
the highest possible score (ie, ceiling effects).
The sequence of psychometric analyses in this study
was designed to ensure proper understanding of the latent
structure before performing the classical psychometric
analyses. The IADCQ latent structure was evaluated with
CFA to assure that the IADCQ scoring matched with the
conceptual framework. We then evaluated the psycho-
metric characteristics of the measures using classical
psychometric techniques and examined the instrument
properties by assessing item-level and scale-level statistics.
All analyses, unless otherwise specified, were conducted
using Statistical Analysis Software (SAS) version 9.1.
Latent structure analyses
Confirmatory factor analysis was used to investigate the
dimensionality of the IADCQ instrument and to ensure
that the scoring approach matches with the latent struc-
ture of the IADCQ. Through an earlier unpublished quali-
tative study, six domains in the IADCQ were identified.
Latent analyses were designed to determine whether the
hypothesized organization of items to domains was con-
sistent with the empirically tested latent structure of the
IADCQ. The rationale for this analysis was to measure the
extent to which the scoring system explains the way that
caregivers respond to the items in the IADCQ to provide
evidence for the structural fidelity of the scoring system
fitting with the latent constructs underlying the IADCQ.
The aggregate data of item responses from the IADCQ
were submitted to CFA appropriate for categorical data.
Specifically, we used a parametric extraction of maximum
likelihood but subjected the covariance matrix to boot-
straps to correct for the influence of non-normality
[26]. Two thousand Bollen-Stine bootstraps were used
during the model estimation to control for multivariate
non-normality. Model fit statistics in CFA provided the
measures with the strength of relationship between the
theoretical model and the data: (1) goodness of fit index
(GFI; measures the amount of variance and covariance
in the data that are reproduced by the tested model); (2)
comparative fit index (CFI; specifies the amount of dif-
ference between the examined model and the independ-
ence model); (3) non-normed fit index (NNFI; conducts
the same task as CFI but takes into consideration the
number of parameters in a model—an aspect that can
inflate CFI); (4) root mean square error of approxima-
tion (RMSEA; determines how well the examined model
reproduces the saturated model); and (5) standardizedroot mean square residual (SRMR; similar to RMSEA
but specifies the absolute measure of model fit). The
model would be considered satisfactory if the five fit
indices met or surpassed these thresholds: GFI ≥ 0.90
[27], CFI and NNFI ≥ 0.95 [27], RMSEA ≤ 0.06 [28], and
SRMR ≤ 0.08 [29]. Confirmatory factor analysis was
conducted using Mplus Version 6.1, a latent variable
modeling program [30].
Item-level analyses
For the item-level psychometric evaluation, five sets of
analyses were planned after the latent analysis following
the methods described in Cole et al. [31]: (1) equality of
item-total correlations for each scale (highest vs. lowest
item-total correlation p > 0.05); (2) equality of variances
for each item per scale (Hartley’s Fmax < 3.0); (3) sufficient
item-total correlations (≥0.40); (4) small alpha removed
statistics (≤0.02); and (5) item-total correlations that
were higher for each item’s own scale than for other
scales (p < 0.05).
Scale-level evaluation
After estimating the item-level psychometrics, the scale-
level properties of the IADCQ domains were examined
in five aspects: (1) scale means and standard deviations;
(2) floor and ceiling scores; (3) internal consistency reli-
ability; (4) test-retest reliability; and (5) convergent valid-
ity. Along with providing descriptive statistics (ie, mean
and standard deviation) for the IADCQ and SF-12v2
scores, we also assessed the overall floor and ceiling
effects of the IADCQ for the purpose of assessing preci-
sion of the instrument, and the percentages of partici-
pants with the floor or ceiling scores were calculated.
Floor and ceiling effects were classified when either was
achieved by more than 5% of the sample.
Internal consistency reliability was measured with two
techniques: coefficient alpha and average inter-item cor-
relation. For coefficient alpha [32], reliability coefficients
of ≥ 90 have been suggested for individual-level analyses
[29], though an internal consistency of ≥ 80 is considered
to be sufficient for most cases [32]. Internal consistency
was also measured with the average inter-item correlation,
which should range from between 0.3 (for a general scale)
to 0.5 (for a specific scale) [33,34].
Test-retest reliability was conducted through a one-
way random effects intra-class correlation coefficient
(ICC) to evaluate the reliability and stability of the
IADCQ and to assess the consistency of the instrument
over time. Because of the short time frame in which the
instruments were administered, it was expected that the
measures of these constructs would either not change or
change minimally. Finally, validity of the IADCQ scale
was analyzed via Pearson correlations with baseline
scores on the SF-12v2 measuring physical and mental
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scales for various measures of HRQoL (all correlations
were expected to be negative given the inverse relation-
ship of healthy scores on the IADCQ and SF-12v2). The
correlations between the IADCQ and the SF-12v2 scores




A total of 200 AD caregivers (80 males, 120 females)
completed the Web-based survey. Overall, 87% of partic-
ipants were between the ages of 30 and 69 years; 40%
were between 30 and 49 years; and 47% were between
50 and 69 years (Table 2). The majority of participants
were white, and a third had been caregivers for < 1 year.
There were 42.5% of participants employed full time (ie,
≥ 30 hours per week), followed by participants who were
employed part time (ie, < 30 hours per week) because of
caregiving responsibilities (13%) or retired (13%). Among
the caregivers who were employed, the majority of par-
ticipants had missed zero to five days from work per
month due to caregiving duties. Details of the demographic
statistics for the test-retest sample are also provided in
Table 2.
Confirmatory factor analysis
The initially theorized, six-factor model was not sup-
ported by CFA. One of the prefaces in latent modeling is
that a single factor should be considered as either the
only factor or as an underlying single factor, subsuming
all other factors; therefore, it is plausible to examine for
their goodness of fit under a default one-factor model
[35]. The goodness of fit of the single-factor model to
the survey data was evaluated using the GFI, CFI [29],
NNFI [36], RMSEA [37], and SRMR [26]. The CFA model
obtained fit that reached most of the acceptance thresh-
olds, where GFI = 0.934, CFI = 0.944, NNFI = 0.934, and
RMSEA = 0.076 (90% confidence interval [CI]: 0.059–
0.090). Although the RMSEA (0.076) was higher than the
ideal value of 0.06, a strong SRMR finding (with the value
of 0.040) suggested that the amount of free parameters
challenged obtaining a favorable RMSEA. The analysis re-
sults indicated that a single-factor model obtained appro-
priate goodness of fit and provided evidence that a simple
sum score of the 12 items of the IADCQ can be used to
measure AD caregiver burden.
The finalized CFA model depicts the strength of the
relationship between each latent trait and its reflective
items, including the standardized path coefficients for
the variables on each of the items, as well as the level of
correlation on the factor (Figure 1). High standardized
factor loadings were observed for all items on the single
factor.IADCQ scoring
The response mean values and the proportions of partic-
ipants with floor and ceiling effects by IADCQ item and
IADCQ total are presented in Table 3. At the item level,
the floor effects (0 = “Not at all”) ranged from 5% (item
12 on Stress) to 34.5% (item 8 on Relationship with AD
patient), whereas the ceiling effects (4 = “Extremely”)
ranged from 2.5% (item 1 on Physical Health) to 18%
(item 12 on Stress). For the IADCQ total score, two
participants had a floor effect (with sum score = 0)
and another two participants had a ceiling effect (with
sum score = 48). A total of 98% of the participants did not
have either floor or ceiling effects, indicating that the
IADCQ covers an ideal range of burden.
Classical psychometric evaluations
Because of the unidimensional model structure identi-
fied through CFA, the following item-level analyses were
conducted (other item-level psychometrics are only ap-
propriate in a multidimensional instrument): item-total
correlations, alpha-removed statistics, and item homo-
geneity. The item-total correlations ranged from 0.523
(item 5 on Worry) to 0.785 (item 12 on Stress), which
were considered as substantial and satisfactory to the
hypothesized scale (Table 4) [35,38,39]. When alpha-if-
item removed statistics were reviewed, removal of any one
item did not lead to an appreciable improvement in co-
efficient alpha. Indeed, only item 5 (on Worry) had an
improvement of any positive magnitude (0.001), but this
improvement was negligible and far below the criterion of
0.02 improvement needed to flag the item as poor [31].
We have also noticed that the correlation of item 5
(Worry) was significantly different from the average cor-
relation of the scale (z score = 2.7; p = 0.006). Nevertheless,
CFA results were not as strong without item 5, providing
a psychometric rationale for keeping it in the scale. No
other items had item-total correlations that were signifi-
cantly lower than the rest of the instrument’s average
item-total correlation. In addition, the Fmax value of 2.23
for the IADCQ indicates similar variances between the
items.
A series of scale-level psychometric evaluations were
conducted (Table 5). Internal consistency reliability of
the IADCQ revealed appropriate results: coefficient
alpha was 0.927 and average inter-item correlation was
0.52. Reliability coefficients for the SF-12v2 scores were
similar to published psychometrics for the general popu-
lation [16]. The IADCQ had a mean scale score of 21.6
and a standard deviation of 10.8, which indicated that
the majority of individuals within the Web-based par-
ticipant population were likely to score along the scale
continuum of 10.8 through 32.4. Convergent validity of
the IADCQ scale was assessed by Pearson correlation
coefficients with the SF-12v2 PCS and MCS scales and
Table 2 Demographics of the Web-based survey participants




Age n % n %
18–29 years 22 11.0% 6 12.0%
30–49 years 79 39.5% 22 44.0%
50–69 years 94 47.0% 21 42.0%
≥ 70 years 5 2.5% 1 2.0%
Gender
Male 80 40.0% 19 38.0%
Female 120 60.0% 31 62.0%
Race
White 169 84.5% 42 84.0%
Black/African American 14 7.0% 4 8.0%
Asian 9 4.5% 4 8.0%
American Indian/Alaskan Native 2 1.0% 0 0.0%
Other 6 3.0% 0 0.0%
History being an AD caregiver
< 6 months 20 10.0% 2 4.0%
6–12 months 45 22.5% 6 12.0%
13–24 months 51 25.5% 14 28.0%
> 2 years 84 42.0% 28 56.0%
Employment status
Full-time homemaker 16 8.0% 4 8.0%
Employed full time (≥30 hours per week) 85 42.5% 26 52.0%
Employed part time because of caregiving responsibilities (<30 hours per week) 26 13.0% 9 18.0%
Employed part time not because of caregiving responsibilities (<30 hours per week) 11 5.5% 5 10.0%
Unemployed because of caregiving responsibilities 17 8.5% 4 8.0%
Unemployed not because of caregiving responsibilities 11 5.5% 0 0.0%
Volunteer/Student 4 2.0% 0 0.0%
Retired 26 13.0% 1 2.0%
Other 4 2.0% 1 2.0%
Days per month missed from work due to caregiving duties
0–5 days 82 67.2% 22 44.0%
6–10 days 28 22.9% 16 32.0%
11–15 days 8 6.6% 1 2.0%
16–20 days 1 0.8% 1 2.0%
21–24 days 3 2.5% 0 0.0%
Abbreviation: AD, Alzheimer’s disease.
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served between the IADCQ and the scales of SF-12v2 with
the Pearson correlation coefficients ranging from −0.58
to −0.20, which indicated a moderate convergent validity.
Negative convergent correlations were expected here
as higher scores on the IADCQ indicate worse func-
tioning, whereas higher scores on the SF-12 indicate
better functioning.Intra-class correlation coefficient
Intra-class correlation coefficient (ICC) for the IADCQ
scale was estimated to assess the test-retest reliability for
the subgroup of 50 AD caregivers who participated in
the Web-based survey at both baseline and 4 weeks
later. The ICC for the IADCQ scale was 0.68 (95% CI:






































Figure 1 Finalized CFA model structure and path coefficients for the 12-item IADCQ. CFA=confirmatory factor analysis; IADCQ=Impact of
Alzheimer’s Disease Caregiver Questionnaire; e=residual variance.
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The objective of this study was to investigate the psycho-
metric characteristics of the IADCQ designed for AD
caregivers as well as to determine the most appropriate
scoring algorithm for the Web-based IADCQ. Our in-
vestigation revealed that the 12-item instrument demon-
strated appropriate unidimensional model fit on the
CFA, a high degree of item-level reliability, good internal
consistency, and moderate test-retest reliability and
moderate convergent validity with the scales of SF-12v2.
Not surprisingly, negative correlations were observed
because higher scores on the IADCQ indicate worse
state with −0.20 for General Health and −0.58 for Mental
Health. The CFA model was found to have strong fit on
most of the indices. Moreover, most of the factor loadings
were in the range of 0.7 to 0.8, indicating that the majority
of the variance for question items was explained by the
factor. The study findings demonstrate that the IADCQ
can be used to measure the burden of AD caregiving andthat the concepts measured in the IADCQ represent a co-
hesive concept of caregiver burden.
In addition to demonstrating psychometrically appro-
priate measurement characteristics, the results suggest
that the IADCQ should be scored as a single scale by
summing up the scores from all 12 items. The sum score
implies the overall burden of AD caregiving across all
theorized areas (ie, emotional, physical, social, financial,
sleep, and time), where a higher score of the IADCQ in-
dicates more burden for an AD caregiver. The IADCQ
measures the burden of the AD caregiver; however, we
recognize that there may be positive aspects associated
with caregiving that are not addressed by our research.
Positive emotions are not included in this newly devel-
oped measurement. Previous research has found add-
itional factors to be important when discussing caregiving,
such as positive emotions from caregiving and resources
that caregivers may aid in managing their challenges of
caregiving [40]. In particular, Stephan et al. have evaluated
Table 3 IADCQ item mean and percentage with floor and ceiling effects
IADCQ Question item Item mean With floor score (0 = "Not at All") With ceiling score (4 = "Extremely")
Concept n %* n %*
Physical health 1.4 44 22.0% 5 2.5%
Impact on time 2.0 23 11.5% 17 8.5%
Sadness 2.0 16 8.0% 19 9.5%
Loneliness 1.5 50 25.0% 14 7.0%
Worry 2.0 34 17.0% 31 15.5%
Frustration 2.2 21 10.5% 35 17.5%
Social activities 2.1 23 11.5% 30 15.0%
Relationship with AD patient 1.3 69 34.5% 14 7.0%
Relationship with friends or family 1.4 49 24.5% 13 6.5%
Personal finances 1.5 54 27.0% 15 7.5%
Sleep 1.9 30 15.0% 22 11.0%
Stress 2.2 10 5.0% 36 18.0%
Entire scale (sum score 0–48) 21.6 2 1.0% 2 1.0%
Abbreviations: AD, Alzheimer’s disease; IADCQ, Impact of Alzheimer’s Disease on Caregiver Questionnaire.
*Percent calculated as n/N (200 Internet-survey participants).
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[41]. Previous development work with the IADCQ did not
consider these factors as the emphasis was on the negative
side of caregiver burden. Readers should consider this
omission of factors when evaluating the comprehensive-
ness of the IADCQ for their needs.
Unlike other caregiver instruments, the IADCQ has
been specifically designed to measure the burden associ-
ated with caregiving for AD patients. Issues that AD care-
givers in particular tend to face, such as the potential forTable 4 Item-level psychometrics




Item 1 Physical health 0.672 0.921
Item 2 Impact on time 0.780 0.917
Item 3 Sadness 0.637 0.922
Item 4 Loneliness 0.701 0.920
Item 5* Worry 0.523 0.928
Item 6 Frustration 0.729 0.919
Item 7 Social activities 0.723 0.919
Item 8 Relationship with
AD patient
0.637 0.923
Item 9 Relationship with
friends or family
0.763 0.918
Item 10 Personal finances 0.579 0.925
Item 11 Sleep 0.763 0.917
Item 12 Stress 0.785 0.917
Overall coefficient alpha 0.927
Abbreviation: AD, Alzheimer’s disease.
*The correlation of Item 5 is significantly different from the average correlation
of the entire scale, where z score is 2.7 and p value is 0.006.the AD patient to harm him/herself or others and the rela-
tionship between the caregiver and the AD patient, are
included in this instrument. This may allow for increased
understanding of how caring specifically for a person with
Alzheimer’s disease impacts the caregiver that other care-
giver instruments may not adequately capture. Addition-
ally, it is appropriate for use in a clinical trial setting
in that it is self-administered, brief (12 easy-to-complete
items), and simple to score and interpret.Table 5 Scale-level psychometrics
Scale Reliability
α rii Mean* SD* Pearson r
with IADCQ*
IADCQ 0.927 0.52 21.62 10.77 **
SF-12 v2: PF 0.801 0.67 47.32 11.33 −0.32
SF-12 v2: RP 0.884 0.79 44.05 10.22 −0.42
SF-12 v2: BP (1 item) ** 45.32 11.26 −0.40
SF-12 v2: GH (1 item) ** 46.38 11.31 −0.20
SF-12 v2: VT (1 item) ** 45.84 10.41 −0.33
SF-12 v2: SF (1 item) ** 42.23 11.11 −0.54
SF-12 v2: RE 0.860 0.76 39.14 11.47 −0.48
SF-12 v2: MH 0.690 0.43 41.96 10.40 −0.57
SF-12 v2: PCS 0.875 0.56 48.18 10.43 −0.26
SF-12 v2: MCS 0.817 0.43 40.17 10.14 −0.58
Abbreviations: α, coefficient alpha; BP, bodily pain; GH, general health; IADCQ,
Impact of Alzheimer’s Disease on Caregiver Questionnaire; MCS, mental health
composite score; MH, mental health; PCS, physical health composite score; PF,
physical functioning; rii , average inter-item correlation; RE, role emotional; RP,
role physical; SD, standard deviation; SF, social functioning; SF-12v2, Short
Form-12 Health Survey Version 2; VT, vitality.
*T-scores for SF-12v2 scales were used in calculation.
**Analyses were not conducted.
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appears to be demographically similar to the AD caregiver
population in the US. The 2009 Behavioral Risk Factor
Surveillance System survey of caregivers of patients with
AD and other dementias found 70% were female, 56%
were ≥ 55 years old, and 44% were employed part or full
time [4]. The Alzheimer’s Association reported 75% of
caregivers had been caregivers for ≥ 1 year; of these, 32%
had been caregivers for ≥ 5 years [5]. However, it should
be noted that because the AD caregivers completed the
questionnaire online, this may not represent those care-
givers who do not have access to the Internet or are not
computer users.
This study is not without limitations. As this study is
the first quantitative evaluation of the IADCQ, its signifi-
cance should not be overstated. The single-factor should
be further validated with independent samples, such as
samples of clinical trial subjects. Indeed, as the originally
postulated construct of the IADCQ did not obtain appro-
priate fit, further validation of the unidimensional model
is important. It is possible that the structure of the origin-
ally hypothesized model did not fit given a combination of
too few items per factor and a sample size of only moder-
ate power.
Additionally, the current research is limited to care-
givers of AD. Extrapolating these findings to caregivers of
dementia patients broadly is not advised based strictly on
the current research. Both regulatory [42] and psychomet-
ric [43] guidance note that without proper assessment
of the similarity of content validity, presuming a larger
cohort (eg, dementia) will appropriately extrapolate to a
more restrictive cohort from which the research is based
(eg, AD) would be inappropriate. Therefore, we caution
against any use of the IADCQ for a caregiver population
of a broader dementia sample without additional research
to establish such efficacy.
Conclusions
In summary, this research supports the use of the Web-
based IADCQ to measure the burden impact on care-
givers of AD patients and justifies a single total-score
interpretation. We found good internal consistency and
moderate reliability and validity. Validation of the paper-
based administration mode of the IADCQ is another area
for future development. Additional psychometric evalu-
ation should be further implemented because validity
and reliability of an instrument in one administration
mode (eg, Web-based survey) cannot be assumed to
hold in an alternate mode (eg, paper-based survey) [37].
When the survey data are collected through other ad-
ministration modes, additional psychometric properties
of the instrument need to be assessed by other applic-
able approaches, such as development of a responder
definition.Abbreviations
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